JP2004526429A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004526429A5 JP2004526429A5 JP2002556746A JP2002556746A JP2004526429A5 JP 2004526429 A5 JP2004526429 A5 JP 2004526429A5 JP 2002556746 A JP2002556746 A JP 2002556746A JP 2002556746 A JP2002556746 A JP 2002556746A JP 2004526429 A5 JP2004526429 A5 JP 2004526429A5
- Authority
- JP
- Japan
- Prior art keywords
- filed
- provisional application
- application
- entirety
- contents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25464800P | 2000-12-07 | 2000-12-07 | |
| US27568801P | 2001-03-13 | 2001-03-13 | |
| PCT/US2001/047349 WO2002055700A2 (en) | 2000-12-07 | 2001-12-07 | Human genes and gene expression products isolated from human prostate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004526429A JP2004526429A (ja) | 2004-09-02 |
| JP2004526429A5 true JP2004526429A5 (enExample) | 2005-05-26 |
Family
ID=26944174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002556746A Withdrawn JP2004526429A (ja) | 2000-12-07 | 2001-12-07 | ヒト前立腺から単離したヒト遺伝子および遺伝子発現産物 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1379651A2 (enExample) |
| JP (1) | JP2004526429A (enExample) |
| AU (1) | AU2002243300A1 (enExample) |
| CA (1) | CA2430794A1 (enExample) |
| WO (1) | WO2002055700A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030215803A1 (en) * | 2000-12-07 | 2003-11-20 | Garcia Pablo Dominguez | Human genes and gene expression products isolated from human prostate |
| US7459539B2 (en) | 2000-12-15 | 2008-12-02 | Agensys, Inc. | Antibody that binds zinc transporter protein 108P5H8 |
| US7271240B2 (en) | 2001-03-14 | 2007-09-18 | Agensys, Inc. | 125P5C8: a tissue specific protein highly expressed in various cancers |
| US8647826B2 (en) | 2001-03-14 | 2014-02-11 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
| US20040081653A1 (en) | 2002-08-16 | 2004-04-29 | Raitano Arthur B. | Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
| JPWO2005080562A1 (ja) * | 2004-02-23 | 2007-08-02 | 弘 山元 | 前立腺癌の判定方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6218529B1 (en) * | 1995-07-31 | 2001-04-17 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
| US6476207B1 (en) * | 1998-06-11 | 2002-11-05 | Chiron Corporation | Genes and gene expression products that are differentially regulated in prostate cancer |
-
2001
- 2001-12-07 JP JP2002556746A patent/JP2004526429A/ja not_active Withdrawn
- 2001-12-07 EP EP01989188A patent/EP1379651A2/en not_active Withdrawn
- 2001-12-07 CA CA002430794A patent/CA2430794A1/en not_active Abandoned
- 2001-12-07 WO PCT/US2001/047349 patent/WO2002055700A2/en not_active Ceased
- 2001-12-07 AU AU2002243300A patent/AU2002243300A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004538039A5 (enExample) | ||
| CY2019029I2 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
| JP2004510493A5 (enExample) | ||
| JP2003531157A5 (enExample) | ||
| JP2005527336A5 (enExample) | ||
| JP2005529946A5 (enExample) | ||
| JP2004500211A5 (enExample) | ||
| CY2014038I1 (el) | Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| NO20041216L (no) | Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt | |
| JP2004210767A5 (enExample) | ||
| JP2003510332A5 (enExample) | ||
| JP2003510400A5 (enExample) | ||
| NO20041200L (no) | Fremgangsmate for fremstilling av citalopram. | |
| JP2006512466A5 (enExample) | ||
| EP1531795A4 (en) | FORMULATIONS FOR LIMITING THE RETENTION OF LUNG INFECTIONS | |
| JP2005536763A5 (enExample) | ||
| JP2006505391A5 (enExample) | ||
| JP2005527457A5 (enExample) | ||
| JP2004526429A5 (enExample) | ||
| JP2005005118A5 (enExample) | ||
| JP2002277470A5 (enExample) | ||
| DK1450626T3 (da) | Ny ikke-antibiotisk strategi mod OGIP-infektioner på basis af et aktiveret kornprodukt | |
| JP2007523200A5 (enExample) | ||
| JP2007531613A5 (enExample) | ||
| NO20040912L (no) | Beskyttede 3,5-dihydroksy-2,2-dimetyl-valeroamider for syntese av epotiloner og derivater derav, og fremgangsmate for fremstilling og andvendelse derav. |